ketoconazole has been researched along with Tinea Versicolor in 83 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Tinea Versicolor: A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions and is mostly caused by MALASSEZIA FURFUR (formerly Pityrosporum orbiculare).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor." | 9.08 | Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. ( Gisoldi, EM; Grossman, RM; Guarnieri, J; Hickman, J; Humeniuk, JM; Klausner, MA; Lange, DS; Pariser, DM; Pariser, RJ; Reyes, BA; Richards, HM; Savin, RC; Sherertz, EF, 1998) |
| "A 4-week, double-blind comparison of ketoconazole and placebo was conducted in sixty-six patients with tinea versicolor." | 9.05 | Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. ( Savin, RC, 1984) |
| "Twenty-two patients with tinea versicolor (pityriasis versicolor) were treated with a single 400 mg dose of ketoconazole and evaluated one month later." | 7.67 | Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. ( Jacobs, PH; Rausch, LJ, 1984) |
| "In our study of 6 month of pityriasis versicolor patient in skin department of Mymensingh Medical College Hospital outdoor, most of the patient was of age 16-25 years (63." | 6.74 | A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. ( Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M, 2009) |
| "Ketoconazole-treated patients who were cured at the end of treatment remained cured 8 weeks later." | 6.66 | Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. ( Horwitz, SN; Savin, RC, 1986) |
| "Ketoconazole 2% foam was evaluated in a single-center, open-label, one-arm pilot study which enrolled eleven subjects to gain 10 evaluable subjects aged 21 years and older with a clinical diagnosis of tinea versicolor and positive KOH using calcofluor." | 5.19 | Can pityriasis versicolor be treated with 2% ketoconazole foam? ( Cantrell, WC; Elewksi, BE, 2014) |
| " The aim of this randomised double-blind study was to compare for the first time, the efficiency and safety of flutrimazole 1% shampoo versus ketoconazole 2% shampoo in the treatment of tinea versicolor." | 5.12 | Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial. ( Gregoriou, S; Ifantides, A; Katsambas, A; Kontochristopoulos, G; Rigopoulos, D, 2007) |
| "Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor." | 5.08 | Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. ( Gisoldi, EM; Grossman, RM; Guarnieri, J; Hickman, J; Humeniuk, JM; Klausner, MA; Lange, DS; Pariser, DM; Pariser, RJ; Reyes, BA; Richards, HM; Savin, RC; Sherertz, EF, 1998) |
| "A 4-week, double-blind comparison of ketoconazole and placebo was conducted in sixty-six patients with tinea versicolor." | 5.05 | Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up. ( Savin, RC, 1984) |
| "Twenty-two patients with tinea versicolor (pityriasis versicolor) were treated with a single 400 mg dose of ketoconazole and evaluated one month later." | 3.67 | Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole. ( Jacobs, PH; Rausch, LJ, 1984) |
| "Our study included all patients with pityriasis versicolor who attended in dermatology department of Habib Thameur Hospital, Tunis (over a 21-month period)." | 2.82 | Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor. ( Badri, T; Bzioueche, N; Hammami, H; Mokhtar, I; Zouari, B, 2016) |
| "Participants with pityriasis versicolor were randomly assigned to two groups: the combination group was treated with adapalene 0." | 2.80 | A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. ( Li, ZG; Shi, TW; Tang, YB; Yu, HX; Yu, JB; Zhang, JA, 2015) |
| "Adapalene was the favorable option in the treatment of pityriasis versicolor." | 2.77 | Roles of adapalene in the treatment of pityriasis versicolor. ( Ren, XK; Shi, TW; Tang, YB; Yu, HX, 2012) |
| "In our study of 6 month of pityriasis versicolor patient in skin department of Mymensingh Medical College Hospital outdoor, most of the patient was of age 16-25 years (63." | 2.74 | A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. ( Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M, 2009) |
| "Ninety patients with extensive pityriasis versicolor (body involved area > or =25%) were randomly assigned to treatment with either a single dose of 400 mg of ketoconazole or with two doses of 300 mg of fluconazole with 2 weeks interval." | 2.73 | Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. ( Azizi, H; Suizi, B; Yazdanpanah, MJ, 2007) |
| "Pityriasis versicolor can be treated by a single or multiple dosage regime of ketoconazole as well as by fluconazole." | 2.70 | Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. ( Baruah, MC; Bhogal, CS; Singal, A, 2001) |
| "Patients with pityriasis versicolor who had not responded at the end of the double-blind period were treated on an open basis with itraconazole (100 mg once daily) for 15 days." | 2.67 | Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo. ( Kint, RT; Mertens, RL; Peremans, W; Roseeuw, D; Van Cutsem, J; Willemsen, M, 1990) |
| "Ketoconazole-treated patients who were cured at the end of treatment remained cured 8 weeks later." | 2.66 | Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. ( Horwitz, SN; Savin, RC, 1986) |
| "Pityriasis versicolor is the probably most frequent infection caused by Malassezia." | 2.52 | [Cutaneous Malassezia infections and Malassezia associated dermatoses: An update]. ( Krüger, C; Mayser, P; Nenoff, P, 2015) |
| "According to current recommendations, pityriasis versicolor should be rapidly treated with antimycotics, followed by ultraviolet therapy to induce maturation of existent melanosomes and accelerate repigmentation." | 2.43 | Pityriasis versicolor alba. ( Krämer, HJ; Mayser, P; Thoma, W, 2005) |
| " The aetiology of the atrophy is still unknown, and two main hypotheses have been formulated, one suggesting a correlation with long-term use of topical steroids and the other a delayed type hypersensitivity to epicutaneous antigens derived from components of the fungus." | 1.46 | Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome. ( Alaibac, M; Marinello, E; Piaserico, S, 2017) |
| "We report two cases of Pityriasis versicolor (PV) in infants aged 12 and 18 months." | 1.46 | [Pityriasis versicolor in infants: unusual clinical presentation and role of corticosteroids used as depigmenting agent for cosmetic purposes in the mother]. ( Bammo, M; Diallo, TAA; Dieng, MT; Dione, H; Diop, BM; Dioussé, P; Gueye, AM; Gueye, RD; Ka, MM; Lizia, S; Ly, F; Sarr, F, 2017) |
| "Clinicians should be aware that vulvar pityriasis versicolor may occur in healthy women with no other skin involvement." | 1.40 | Vulvar pityriasis versicolor in an immunocompetent woman. ( Day, T; Scurry, J, 2014) |
| "Pityriasis versicolor is common among young active duty members with overactive sweat glands working in humid environments and results in pigmentary changes that can be profound in those with darker skin." | 1.39 | Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy. ( Rivard, SC, 2013) |
| "This variant of pityriasis versicolor should be considered in the differential diagnosis of seborrheic dermatitis and dermatitis neglecta." | 1.33 | Hyperkeratotic head and neck Malassezia dermatosis. ( Boralevi, F; Buzenet, C; Couprie, B; Lepreux, S; Marco-Bonnet, J; Taïeb, A, 2006) |
| "Pityriasis versicolor is a superficial fungal infection of the skin caused by Malassezia furfur (Pityrosporum orbiculare) which is a part of the normal flora of the human skin." | 1.29 | Penile involvement in pityriasis versicolor. ( Aljabre, SH; Sheikh, YH, 1994) |
| "Pityriasis versicolor was found to be predominant in the age group of 21--30 years." | 1.28 | Pityriasis versicolor--epidemiological and therapeutical study. ( Kubec, K; Selim, MM, 1989) |
| "Tinea versicolor is a common superficial fungal infection that typically affects young adults in warm, humid climates." | 1.28 | Tinea versicolor of the face in black children in a temperate region. ( Brodell, RT; Kyanko, ME; Pontasch, MJ, 1989) |
| "Long-standing disseminated lesions of pityriasis versicolor (PV) were found in 101 patients." | 1.27 | Ketoconazole--an effective treatment for disseminated pityriasis versicolor. ( Kahana, M; Levy, A; Schewach-Millet, M; Shalish, L; Sommer, B; Yaron-Schiffer, O, 1984) |
| "Apart from the standard treatment of pityriasis versicolor with selenium disulphide preparations, the 30-day-therapy with ketoconazole has been considered an alternative so far." | 1.27 | [10-day therapy of pityriasis versicolor with ketoconazole]. ( Meisel, C, 1983) |
| "Ketoconazole (1 mg/kg) was effective in all four animals." | 1.27 | Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo. ( Faergemann, J, 1988) |
| "My favourite treatment for pityriasis versicolor is propylene glycol 50% in water applied with a gauze pad twice daily for 2 weeks." | 1.27 | Current treatment of cutaneous Pityrosporum and Candida-infections. ( Faergemann, J, 1986) |
| "Ketoconazole is a new antifungal drug, used for oral treatment, with a broad spectrum of activity." | 1.27 | Ketoconazole treatment in superficial mycoses. ( Cervetti, O; Forte, M; Puiatti, P; Zina, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (43.37) | 18.7374 |
| 1990's | 15 (18.07) | 18.2507 |
| 2000's | 13 (15.66) | 29.6817 |
| 2010's | 17 (20.48) | 24.3611 |
| 2020's | 2 (2.41) | 2.80 |
| Authors | Studies |
|---|---|
| Bakr, E | 1 |
| Abdo, H | 1 |
| Abd-Elaziz, H | 1 |
| Abd-Elrazek, H | 1 |
| Amer, M | 1 |
| Dioussé, P | 1 |
| Ly, F | 1 |
| Bammo, M | 1 |
| Lizia, S | 1 |
| Diallo, TAA | 1 |
| Dione, H | 1 |
| Sarr, F | 1 |
| Gueye, RD | 1 |
| Gueye, AM | 1 |
| Dieng, MT | 1 |
| Diop, BM | 1 |
| Ka, MM | 1 |
| Liu, XK | 1 |
| Li, J | 1 |
| Greco, V | 1 |
| Megna, M | 1 |
| Luciano, MA | 1 |
| Fabbrocini, G | 1 |
| Brandi, N | 1 |
| Starace, M | 1 |
| Alessandrini, A | 1 |
| Piraccini, BM | 1 |
| Choi, FD | 1 |
| Juhasz, MLW | 1 |
| Atanaskova Mesinkovska, N | 1 |
| Helou, J | 1 |
| Obeid, G | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Rivard, SC | 1 |
| Kallini, JR | 1 |
| Khachemoune, A | 1 |
| Day, T | 1 |
| Scurry, J | 1 |
| Shi, TW | 2 |
| Zhang, JA | 1 |
| Tang, YB | 2 |
| Yu, HX | 2 |
| Li, ZG | 1 |
| Yu, JB | 1 |
| Cantrell, WC | 1 |
| Elewksi, BE | 1 |
| Nenoff, P | 2 |
| Krüger, C | 1 |
| Mayser, P | 2 |
| Gobbato, AA | 1 |
| Babadópulos, T | 1 |
| Gobbato, CA | 1 |
| Ilha, Jde O | 1 |
| Gagliano-Jucá, T | 1 |
| De Nucci, G | 1 |
| Badri, T | 1 |
| Hammami, H | 1 |
| Bzioueche, N | 1 |
| Zouari, B | 1 |
| Mokhtar, I | 1 |
| Suzuki, C | 1 |
| Hase, M | 1 |
| Shimoyama, H | 1 |
| Sei, Y | 1 |
| Marinello, E | 1 |
| Piaserico, S | 1 |
| Alaibac, M | 1 |
| Muhammad, N | 1 |
| Kamal, M | 2 |
| Islam, T | 1 |
| Islam, N | 1 |
| Shafiquzzaman, M | 1 |
| Nevas, J | 1 |
| Ren, XK | 1 |
| Usatine, RP | 1 |
| Fogl, T | 1 |
| Margolese, HC | 1 |
| Thoma, W | 1 |
| Krämer, HJ | 1 |
| Abraham, S | 1 |
| Piguet, V | 1 |
| Boralevi, F | 1 |
| Marco-Bonnet, J | 1 |
| Lepreux, S | 1 |
| Buzenet, C | 1 |
| Couprie, B | 1 |
| Taïeb, A | 1 |
| Miranda, KC | 1 |
| de Araujo, CR | 1 |
| Costa, CR | 1 |
| Passos, XS | 1 |
| de Fátima Lisboa Fernandes, O | 1 |
| do Rosário Rodrigues Silva, M | 1 |
| Rigopoulos, D | 1 |
| Gregoriou, S | 1 |
| Kontochristopoulos, G | 1 |
| Ifantides, A | 1 |
| Katsambas, A | 1 |
| Yazdanpanah, MJ | 1 |
| Azizi, H | 1 |
| Suizi, B | 1 |
| Di Fonzo, EM | 1 |
| Martini, P | 1 |
| Mazzatenta, C | 1 |
| Lotti, L | 1 |
| Alvino, S | 1 |
| Schewach-Millet, M | 2 |
| Kahana, M | 2 |
| Levy, A | 2 |
| Yaron-Schiffer, O | 1 |
| Sommer, B | 1 |
| Shalish, L | 1 |
| Giam, YC | 2 |
| Rajan, VS | 1 |
| Hay, RJ | 1 |
| Midgeley, G | 1 |
| Rausch, LJ | 1 |
| Jacobs, PH | 3 |
| Faergemann, J | 6 |
| Grimmer, H | 1 |
| Jolliffe, DS | 1 |
| Ngai, YL | 1 |
| Urcuyo, FG | 1 |
| Zaias, N | 2 |
| Jones, HE | 1 |
| Djärv, L | 1 |
| Caterall, MD | 1 |
| Meinhof, W | 1 |
| Meisel, C | 1 |
| Auffret, N | 1 |
| Deutsch, PH | 1 |
| Quintiliani, R | 1 |
| Schramm, P | 1 |
| Savin, RC | 3 |
| Yaron-Shiffer, O | 1 |
| Sadeque, JB | 1 |
| Shahidullah, M | 1 |
| Shah, OR | 1 |
| Aljabre, SH | 1 |
| Sheikh, YH | 1 |
| Valsecchi, R | 1 |
| Pansera, B | 1 |
| di Landro, A | 1 |
| Cainelli, T | 1 |
| Fernandez-Nava, HD | 1 |
| Laya-Cuadra, B | 1 |
| Tianco, EA | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Goodless, DR | 2 |
| Lange, DS | 1 |
| Richards, HM | 1 |
| Guarnieri, J | 1 |
| Humeniuk, JM | 1 |
| Reyes, BA | 1 |
| Hickman, J | 1 |
| Pariser, DM | 2 |
| Pariser, RJ | 1 |
| Sherertz, EF | 1 |
| Grossman, RM | 1 |
| Gisoldi, EM | 1 |
| Klausner, MA | 1 |
| el Euch, D | 1 |
| Riahi, I | 1 |
| Mokni, M | 1 |
| Ben Osman, A | 1 |
| Mezlini, S | 1 |
| Abidi, H | 1 |
| Reinl, P | 1 |
| Haustein, UF | 1 |
| Bhogal, CS | 1 |
| Singal, A | 1 |
| Baruah, MC | 1 |
| Farschian, M | 1 |
| Yaghoobi, R | 1 |
| Samadi, K | 1 |
| Borelli, D | 1 |
| Nall, L | 2 |
| Ramos-Caro, FA | 1 |
| Flowers, FP | 1 |
| Rekacewicz, I | 1 |
| Guillaume, JC | 1 |
| Benkhraba, F | 1 |
| Archimbaud, A | 1 |
| Baspeyras, M | 1 |
| Boitier, F | 1 |
| Bussière, M | 1 |
| Coin, A | 1 |
| Di Crezenzo, MC | 1 |
| Duval, J | 1 |
| Roseeuw, D | 1 |
| Willemsen, M | 1 |
| Kint, RT | 1 |
| Peremans, W | 1 |
| Mertens, RL | 1 |
| Van Cutsem, J | 2 |
| Delescluse, J | 2 |
| Selim, MM | 1 |
| Kubec, K | 1 |
| Robertson, LI | 1 |
| Cauwenbergh, G | 3 |
| Borghys, AM | 1 |
| Dupré, K | 1 |
| Mariën, K | 1 |
| Degreef, H | 2 |
| Pontasch, MJ | 1 |
| Kyanko, ME | 1 |
| Brodell, RT | 1 |
| del Palacio Hernanz, A | 1 |
| Frias-Iniesta, J | 1 |
| Gonzalez-Valle, O | 1 |
| Borgers, M | 1 |
| Tham, SN | 1 |
| Alteras, I | 1 |
| Sandbank, M | 1 |
| Segal, R | 1 |
| Puiatti, P | 1 |
| Cervetti, O | 1 |
| Forte, M | 1 |
| Zina, G | 1 |
| Kamp, W | 1 |
| Schirren, C | 1 |
| Horwitz, SN | 1 |
| Lorenzini, R | 1 |
| Mercantini, R | 1 |
| De Bernardis, F | 1 |
| Seeliger, HP | 1 |
9 reviews available for ketoconazole and Tinea Versicolor
| Article | Year |
|---|---|
Topical ketoconazole: a systematic review of current dermatological applications and future developments.
Topics: Administration, Topical; Alopecia; Antifungal Agents; Dermatitis, Seborrheic; Humans; Ketoconazole; | 2019 |
[Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].
Topics: Antifungal Agents; Dermatitis, Atopic; Dermatitis, Seborrheic; Itraconazole; Ketoconazole; Malassezi | 2015 |
Pityriasis versicolor alba.
Topics: Antifungal Agents; History, 19th Century; Humans; Ketoconazole; Malassezia; Microscopy, Electron; Sk | 2005 |
Ketoconazole.
Topics: Candidiasis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Chemical Phenomena; Chemistry; C | 1984 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
[The yeast fungus Malassezia: pathogen, pathogenesis and therapy].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Dermatitis, Atop | 2001 |
Tinea versicolor: epidemiologic, clinical, and therapeutic aspects.
Topics: Adult; Diagnosis, Differential; Female; Humans; Ketoconazole; Male; Recurrence; Terminology as Topic | 1991 |
Ketoconazole in the treatment of pityriasis versicolor: international review of clinical trials.
Topics: Humans; Ketoconazole; Tinea Versicolor | 1991 |
Itraconazole in tinea versicolor: a review.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Tinea Versicolor | 1990 |
28 trials available for ketoconazole and Tinea Versicolor
| Article | Year |
|---|---|
Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Gels; Humans; Ketoconazole; Ointments; Tinea Versicol | 2020 |
A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor.
Topics: Adapalene; Adult; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Tinea Versicolor; Y | 2015 |
Can pityriasis versicolor be treated with 2% ketoconazole foam?
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Female; Follow-Up Studies; Humans; Ketoconazole | 2014 |
A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.
Topics: Administration, Cutaneous; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans | 2015 |
Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasis versicolor.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Hair Pre | 2016 |
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Bangladesh; Female; Fluconazole; Humans; Incidence; Itraconazo | 2009 |
Roles of adapalene in the treatment of pityriasis versicolor.
Topics: Adapalene; Adult; Dermatologic Agents; Female; Gels; Humans; Ketoconazole; Male; Middle Aged; Naphth | 2012 |
Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
Topics: Adult; Antifungal Agents; Clotrimazole; Double-Blind Method; Female; Hair Preparations; Humans; Keto | 2007 |
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Iran; Ketoconazole; Male; Surveys and Questio | 2007 |
Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
Topics: Administration, Topical; Adult; Animals; Female; Humans; Ketoconazole; Male; Prospective Studies; Ti | 2008 |
Oral Ketoconazole--a new treatment for Tinea Versicolor.
Topics: Administration, Oral; Adolescent; Adult; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Fe | 1984 |
Short course ketoconazole therapy in pityriasis versicolor.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Ketoconazole; Random Allocation; | 1984 |
The successful treatment of pityriasis versicolor by systemic ketoconazole.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Clinical Trials as Topic; Double-Blind M | 1982 |
Tinea versicolor: treatment and prophylaxis with ketoconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Follow-Up Studies; Humans; Imidazoles; Ketoconaz | 1982 |
Systemic ketoconazole in tinea versicolor: a double-blind evaluation and 1-year follow-up.
Topics: Administration, Oral; Adolescent; Adult; Blood Cell Count; Double-Blind Method; Drug Evaluation; Fem | 1984 |
Systemic ketoconazole in the treatment of tinea versicolor.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; | 1995 |
Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Female; Humans; Ketoconazole; Male; Midd | 1997 |
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Femal | 1998 |
[Ketoconazole foaming gel in tinea versicolor (report of 60 cases)].
Topics: Administration, Topical; Adult; Antifungal Agents; Female; Gels; Humans; Ketoconazole; Male; Tinea V | 1999 |
Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Child; Drug Administration Schedule; Fem | 2001 |
Fluconazole versus ketoconazole in the treatment of tinea versicolor.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration | 2002 |
[A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor].
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Drug Tolerance; Female; Humans; Ketoconazole; | 1990 |
Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Double-Blind M | 1990 |
Pityriasis versicolor with ketoconazole.
Topics: Administration, Oral; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Clinical Trials as | 1989 |
Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study.
Topics: Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole; Male; Mid | 1988 |
Itraconazole therapy in pityriasis versicolor.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Itraconazole; | 1986 |
Ketoconazole in Tinea versicolor: is ten day therapy adequate?
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; Female; Humans; | 1987 |
Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor.
Topics: Administration, Topical; Adolescent; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Hu | 1986 |
46 other studies available for ketoconazole and Tinea Versicolor
| Article | Year |
|---|---|
[Pityriasis versicolor in infants: unusual clinical presentation and role of corticosteroids used as depigmenting agent for cosmetic purposes in the mother].
Topics: Antifungal Agents; Female; Glucocorticoids; Humans; Hydroquinones; Infant; Ketoconazole; Male; Mothe | 2017 |
A hyperpigmented intermammary patch.
Topics: Antifungal Agents; Female; Humans; Ketoconazole; Ointments; Thorax; Tinea Versicolor; Treatment Outc | 2018 |
Pityriasis versicolor with uncommon localizations.
Topics: Adult; Antifungal Agents; Back; Extremities; Humans; Itraconazole; Ketoconazole; Knee; Male; Organ S | 2020 |
Tinea versicolor of the neck as side effect of topical steroids for alopecia areata.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Antifungal Agents; Clobetasol; Drug Adm | 2019 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconaz | 2014 |
Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Hair Preparations; Humans; Ketoconazole; Male; Ti | 2013 |
Multiple hyperpigmented macules on the torso of a dark-skinned man.
Topics: Antifungal Agents; Diagnosis, Differential; Humans; Hyperpigmentation; Ketoconazole; Male; Middle Ag | 2013 |
Vulvar pityriasis versicolor in an immunocompetent woman.
Topics: Administration, Topical; Antifungal Agents; Biopsy; Female; Humans; Ketoconazole; Skin; Tinea Versic | 2014 |
Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Antifungal Agents; Dermatology; Fe | 2016 |
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Atrophy; Female; Humans; Ketoconazole; Sjogren' | 2017 |
Tinea versicolor: understanding effective treatment options.
Topics: Antifungal Agents; Humans; Ketoconazole; Malassezia; Nursing Assessment; Nursing Methodology Researc | 2012 |
Variations in color.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Black People; Diagnosis, | 2003 |
Fungal dermatitis with olanzapine in schizophrenia.
Topics: Adult; Antifungal Agents; Antipsychotic Agents; Benzodiazepines; Drug Eruptions; Humans; Ketoconazol | 2003 |
An unusual presentation of malassezia dermatosis.
Topics: Antifungal Agents; Facial Dermatoses; Head; Humans; Ketoconazole; Malassezia; Neck; Terminology as T | 2006 |
Hyperkeratotic head and neck Malassezia dermatosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Diagnosis, Differential; Facial Dermatoses; Female; | 2006 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Mal | 2007 |
Ketoconazole--an effective treatment for disseminated pityriasis versicolor.
Topics: Administration, Oral; Adolescent; Adult; Child; Female; Humans; Ketoconazole; Male; Middle Aged; Rec | 1984 |
Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole.
Topics: Adolescent; Adult; Female; Humans; Ketoconazole; Male; Middle Aged; Tinea Versicolor | 1984 |
In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare.
Topics: Animals; Antifungal Agents; Itraconazole; Ketoconazole; Malassezia; Male; Microbial Sensitivity Test | 1984 |
[Ketoconazole a new broad spectrum antimycotic].
Topics: Adolescent; Adult; Aged; Candida; Candidiasis; Child; Female; Humans; Imidazoles; Ketoconazole; Mala | 1980 |
Systemic treatment of tinea versicolor with ketoconazole in forty-four patients.
Topics: Adolescent; Adult; Antifungal Agents; Child; Female; Humans; Imidazoles; Ketoconazole; Male; Middle | 1981 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomyco | 1982 |
Ketoconazole therapy for pityriasis versicolor.
Topics: Antifungal Agents; Humans; Imidazoles; Ketoconazole; Piperazines; Selenium; Selenium Compounds; Tine | 1982 |
[Ketoconazole--a change in antimycotic therapy?].
Topics: Aged; Antifungal Agents; Candidiasis, Cutaneous; Chemical and Drug Induced Liver Injury; Dermatomyco | 1983 |
[10-day therapy of pityriasis versicolor with ketoconazole].
Topics: Adult; Female; Humans; Ketoconazole; Malassezia; Male; Skin; Tablets; Tinea Versicolor | 1983 |
[Pityriasis versicolor].
Topics: Antifungal Agents; Diagnosis, Differential; Humans; Ketoconazole; Tinea Versicolor | 1984 |
[Seminal fluid concentration of ketoconazole and its effect on spermatozoa motility].
Topics: Adult; Dose-Response Relationship, Drug; Humans; Ketoconazole; Male; Semen; Sperm Motility; Tinea Ve | 1984 |
Drug eruption following ketoconazole therapy.
Topics: Adult; Drug Eruptions; Female; Humans; Ketoconazole; Tinea Versicolor | 1984 |
Penile involvement in pityriasis versicolor.
Topics: Adult; Humans; Ketoconazole; Male; Penile Diseases; Tinea Versicolor | 1994 |
Contact dermatitis from ketoconazole.
Topics: Adult; Drug Eruptions; Female; Humans; Ketoconazole; Male; Patch Tests; Tinea; Tinea Versicolor | 1993 |
Ketoconazole for the treatment of tinea versicolor.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Humans; Ketoconazole; Tinea Versicolor | 1998 |
Discovering antimycotic drugs: today and tomorrow.
Topics: Antifungal Agents; Azoles; Candidiasis; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; | 1990 |
Tinea versicolor. A practical guide for primary care physicians.
Topics: Administration, Oral; Administration, Topical; Humans; Ketoconazole; Recurrence; Tinea Versicolor | 1990 |
Pityriasis versicolor--epidemiological and therapeutical study.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Female; Humans; Infant; Ketoconazole; | 1989 |
Itraconazole in the treatment of widespread tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Female; Humans; Itraconazole | 1987 |
Experience with itraconazole in treatment of fungal infections.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Drug Evaluation; Female; Humans; Itrac | 1987 |
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure- | 1988 |
Tinea versicolor of the face in black children in a temperate region.
Topics: Black People; Child; Clotrimazole; Diagnosis, Differential; Facial Dermatoses; Humans; Ketoconazole; | 1989 |
Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor.
Topics: Administration, Oral; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male | 1986 |
Treatment of pityriasis versicolor with itraconazole.
Topics: Adult; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Random Allocation; Tinea | 1987 |
Current treatment of cutaneous Pityrosporum and Candida-infections.
Topics: Adrenal Cortex Hormones; Candidiasis, Cutaneous; Chronic Disease; Diabetes Complications; Humans; Im | 1986 |
Two years of follow-up of oral ketoconazole therapy in 60 cases of pityriasis versicolor.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Female; Follow-Up Studies; Humans; Ketoc | 1987 |
Ketoconazole treatment in superficial mycoses.
Topics: Adolescent; Adult; Candidiasis, Cutaneous; Child; Child, Preschool; Dermatomycoses; Humans; Ketocona | 1986 |
[Observation of a case of dermatomycosis over a 25-year period. A contribution to the discussion of the concept of griseofulvin resistance].
Topics: Drug Resistance, Microbial; Epidermophyton; Griseofulvin; Humans; Ketoconazole; Male; Middle Aged; T | 1986 |
In vitro sensitivity of Malassezia spp. to various antimycotics.
Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Dog Diseases; Dogs; Econazole; Humans; Ket | 1985 |
[Prevention of mycoses caused by yeasts].
Topics: Candidiasis; Cryptococcosis; Disinfection; Humans; Infant; Infant, Newborn; Infant, Premature, Disea | 1985 |